• 1.

    Gérardin P et al.Encephalchik Study Group , 2016. Chikungunya virus-associated encephalitis: a cohort study on La Réunion Island, 2005–2009. Neurology 86: 94102.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Ledermann JP, Powers AM, 2016. Analysis of CHIKV in mosquitoes infected via artificial blood meal. Methods Mol Biol 1426: 129142.

  • 3.

    Mawuntu AHP, Bernadus JBB, Dhenni R, Wiyatno A, Anggreani R, 2018. Detection of central nervous system viral infections in adults in Manado, North Sulawesi, Indonesia. PLoS One 13: e0207440.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 18231826.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Quick J et al., 2017. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc 12: 12611276.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Mehta R, Gerardin P, de Brito CAA, Soares CN, Ferreira MLB, Solomon T, 2018. The neurological complications of chikungunya virus: a systematic review. Rev Med Virol 28: e1978.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Renault P et al., 2007. A major epidemic of Chikungunya virus infection on Réunion Island, France, 2005–2006. Am J Trop Med Hyg 77: 727731.

  • 8.

    Chusri S, Siripaitoon P, Hirunpat S, Silpapojakul K, 2011. Case reports of neuro-Chikungunya in southern Thailand. Am J Trop Med Hyg 85: 386389.

  • 9.

    Chandak N, Kashyap R, Kabra D, Karandikar P, Saha S, Morey S, Purohit H, Taori G, Daginawala H, 2009. Neurological complications of Chikungunya virus infection. Neurol India 57: 177.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Brito Ferreira ML, 2020. Neurological disease in adults with Zika and Chikungunya virus infection in northeast Brazil: a prospective observational study. Lancet Neurol 19: 826839.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Duong V et al., 2012. Reemergence of chikungunya virus in Cambodia. Emerg Infect Dis 18: 20662069.

  • 12.

    Harapan H, Michie A, Mudatsir M, Nusa R, Yohan B, Wagner AL, Sasmono RT, Imrie A, 2019. Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis. BMC Infect Dis 19: 243.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Kosasih H et al., 2013. Evidence for endemic Chikungunya virus infections in Bandung, Indonesia. PLoS Negl Trop Dis 7: e2483.

  • 14.

    Arif M et al., 2020. Chikungunya in Indonesia: epidemiology and diagnostic challenges. PLoS Negl Trop Dis 14: e0008355.

  • 15.

    Sasmono RT, Perkasa A, Yohan B, Haryanto S, Yudhaputri FA, Hayati RF, Ma’roef CN, Ledermann JP, Aye Myint KS, Powers AM, 2017. Chikungunya detection during dengue outbreak in Sumatra, Indonesia: clinical manifestations and virological profile. Am J Trop Med Hyg 97: 13931398.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Capeding MR et al., 2013. Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children. PLoS Negl Trop Dis 7: e2331.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Lewthwaite P et al., 2009. Chikungunya virus and central nervous system infections in children, India. Emerg Infect Dis 15: 329331.

  • 18.

    Mahto SK, Gupta PK, Singh A, Meena RC, 2018. Atypical neurological manifestations of chikungunya fever: two case reports. Indian J Crit Care Med 22: 306308.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Staples JE, Breiman RF, Powers AM, 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 49: 942948.

  • 20.

    Horwood PF et al., 2017. Aetiology of acute meningoencephalitis in Cambodian children, 2010–2013. Emerg Microbes Infect 6: 18.

  • 21.

    Johnson BW, Goodman CH, Holloway K, de Salazar PM, Valadere AM, Drebot MA, 2016. Evaluation of commercially available Chikungunya virus immunoglobulin M detection assays. Am J Trop Med Hyg 95: 182192.

    • Crossref
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 789 789 161
Full Text Views 219 219 115
PDF Downloads 118 118 50
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

Neurological Disease Associated with Chikungunya in Indonesia

View More View Less
  • 1 Eijkman Institute for Molecular Biology, Jakarta, Indonesia;
  • | 2 Faculty of Medicine, Universitas Sam Ratulangi, R.D. Kandou Hospital, Manado, Indonesia;
  • | 3 Raden Mattaher Hospital, Jambi, Indonesia;
  • | 4 Faculty of Medicine and Health Sciences, Universitas Jambi, Jambi, Indonesia;
  • | 5 Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia;
  • | 6 Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia;
  • | 7 KS Prima Laboratory, Jambi, Indonesia;
  • | 8 Centers for Disease Control and Prevention, Fort Collins, Colorado;
  • | 9 Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands;
  • | 10 Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia;
  • | 11 Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom
Restricted access

ABSTRACT.

Chikungunya virus (CHIKV) is recognized but rarely considered as a cause of central nervous system infection in endemic areas. A total of 244 patients with acute meningoencephalitis in Indonesia were retrospectively tested to identify whether any CHIKV infection was associated with neurological manifestations, especially in provinces known for CHIKV endemicity. Cerebrospinal fluid (CSF) and blood specimens were tested using CHIKV-specific real-time reverse transcription polymerase chain reaction and IgM ELISA, alongside a panel of neurotropic viruses. We report four cases of suspected or confirmed CHIKV-associated neurological disease, including CHIKV RNA detection in CSF of one patient and in acute serum of another, and CHIKV IgM in CSF of three patients and in serum of a fourth. In conclusion, CHIKV should be considered as a cause of neurologic disease in endemic areas and especially during outbreaks, in addition to the more common arboviral diseases such as dengue and Japanese encephalitis viruses.

Author Notes

Address correspondence to Khin S. A. Myint, Emerging Virus Research Unit, Eijkman Institute for Molecular Biology, Jalan Pangeran Diponegoro No. 69, DKI Jakarta, Indonesia. E-mail: khinsawying@hotmail.com

Financial support: This work was supported by the Ministry of Research and Technology, Republic of Indonesia; Sam Ratulangi University Medical Faculty; Faculty of Medicine and Health Sciences, Universitas Jambi; and the U.S. Centers for Disease Control and Prevention. The Indonesia Brain Infection Study received support from the U.S. National Institutes of Health through the ULTIMATE project (Grant no. R01AI145781). RLH is supported by the Wellcome Trust.

Disclaimers: The funding institutions did not participate in study design, data collection or analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Authors’ addresses: Khin S. A. Myint, Yora P. Dewi, Edison Johar, and Frilasita A. Yudhaputri, Eijkman Institute for Molecular Biology, Jakarta, Indonesia, E-mails: khinsawying@hotmail.com, yoradewi@eijkman.go.id, edisonjohar@eijkman.go.id, and sisi@eijkman.go.id. Arthur H. P. Mawuntu, Riane Anggreani, Janno B. B. Bernadus, David Susanto, and Lidia Gaghiwu, Faculty of Medicine, Universitas Sam Ratulangi, R. D. Kandou Hospital, Manado, Indonesia, E-mails: arthur_mawuntu@yahoo.com, ririanggreani636@gmail.com, jannobernadusmd@gmail.com, david_susanto@outlook.com, and gaghiwulidia@gmail.com. Sotianingsih Haryanto and Mirna M. Iskandar, Raden Mattaher Hospital, Jambi, Indonesia, and Faculty of Medicine and Health Sciences, Universitas Jambi, Jambi, Indonesia, E-mails: sotianingsih@yahoo.com and mirnamiskandar@gmail.com. Darma Imran, Kartika Maharani, and Riwanti Estiasari, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, E-mails: darma_imran@yahoo.com, tikamaharanimd@gmail.com, and estiasari@gmail.com. Sofiati Dian and Ahmad R. Ganiem, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, E-mails: sofiatidian@gmail.com and rizalbdg@gmail.com. Hasna Dewi, Faculty of Medicine and Health Sciences, Universitas Jambi, Jambi, Indonesia, E-mail: hasnadewidr@gmail.com. Amanda Kristiani, KS Prima Laboratory, Jambi, Indonesia, E-mail: amandakristianii@gmail.com. Ungke Antonjaya, Eijkman Institute for Molecular Biology, Jakarta, Indonesia, and Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia, E-mail: ungkeajy@gmail.com. Jeremy P. Ledermann and Ann M. Powers, Centers for Disease Control and Prevention, Fort Collins, CO, E-mails: jledermann@cdc.gov and apowers@cdc.gov. Reinout van Crevel, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands, E-mail: reinout.vancrevel@radboudumc.nl. Raph L. Hamers, Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia, and Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom, E-mail: rhamers@eocru.org.

Save